No Data Yet
Tempus AI's third-quarter 2025 revenue surged 84.7% year-over-year to $334.2 million, driven by a 117% increase in its genomics division.
Stryker (SYK), Tempus AI (TEM), and GE HealthCare (GEHC) are identified as key beneficiaries of AI integration in MedTech, a sector that saw 209 AI-enabled medical devices receive FDA approval in 2025.